Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

June Health vs Luvo Health

June Health
Graded #261

Higher grade

vs+2
Luvo Health
Graded #305

Lower grade

The verdict

June Health takes it — 63/100 to 61/100, but only just.

June Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. June Health is a direct-to-consumer telehealth storefront selling compounded GLP-1 medication for weight loss, alongside peptide, hormone, and hair-loss programs, all delivered online with no office visits. Luvo Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueJune Health +23
61
38
Dose & formulationLuvo Health +13
75
88
Clinical oversightLuvo Health +9
59
68
Labs & monitoringLuvo Health +1
51
52
FulfillmentEven
74
74
Contract termsJune Health +10
55
45
June Health · left barLuvo Health · right bar

The numbers

MetricJune HealthLuvo Health
WeighScore63/10061/100
GradeCC
Scorecard rank#261#305
Semaglutide$179/mo (starting dose, compounded)$249/mo (compounded)
Tirzepatide$179/mo (starting dose, compounded)$339/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesYes
June Health

Graded #261 · C

Strengths

  • Offers both injectable and oral compounded semaglutide and tirzepatide
  • Semaglutide starts at $179/mo (injectable) or $187/mo (tablets) — tirzepatide from $179/mo (injectable)
  • Full per-dose price list published on-site with no signup required to view it
  • Provider consult ('licensed clinician evaluation') is bundled into the displayed price
  • Free discreet shipping advertised with 2-3 day delivery

Where it loses points

  • No accessible Terms of Service or Privacy Policy — footer links go nowhere and standard URL guesses 404
  • No LegitScript seal or other pharmacy-verification badge found anywhere on the site
  • Legal entity, prescribing medical group, and compounding pharmacy partner are not named
  • Domain was registered in May 2026 — a brand-new storefront with no independent reviews found
  • Also sells 'MR-3' (retatrutide), a GLP-1/GIP/glucagon agonist with no FDA approval for any use
Luvo Health

Graded #305 · C

Strengths

  • Full price list published openly, by medication and by commitment length, with no intake required
  • Offers both compounded and brand-name Ozempic and Zepbound in one place
  • Oral semaglutide tablets available as well as injections
  • Full refund if a provider disqualifies you before medication is ordered
  • LegitScript certification verified against the issued seal, not just the badge

Where it loses points

  • Billed per 4 weeks, not per month, which is 13 charges a year rather than 12
  • You are charged for the first period as soon as you complete the intake form, before a clinician has reviewed you
  • Refunds stop once medication is ordered, and for new patients with no video visit that is at intake submission
  • Cancellation needs 72 hours notice before the billing date or you are charged for another cycle
  • Bundle refunds are recalculated at the standard non-bundled rate, so the multi-month discount is clawed back

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard